@@@@@_____Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity☆ _ Julio Tobón - Academia

Embed Size (px)

Citation preview

  • 8/9/2019 @@@@@_____Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity _ Julio Tobn - Aca

    1/9

    17/4/2014 Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity| Julio Tobn - Academia.edu

    http://www.academia.edu/4712295/Curcumin_restores_Nrf2_levels_and_prevents_quinol inic_acid- induced_neurotoxici ty_ 1/9

    Home

    Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicityby Julio Tobn

    more

    CurcuminrestoresNrf2levelsandpreventsquinolinicacid-inducedneurotoxicity

    IvnCarmona-Ramreza,AbelSantamarab,JulioC.Tobn-Velascob, c,MarisolOrozco-Ibarra d,IrmaG.Gonzlez-Herrerab,JosPedraza-Chaverr c,PerlaD.Maldonadoa,

    aPatologaVascularCerebral,InstitutoNacionaldeNeurologayNeurociruga ManuelVelascoSurez,MxicoD.F.,14269,MxicobAminocidosExcitadores,InstitutoNacionald eNeurologay Neurociruga ManuelVelascoSurez,MxicoD.F.,14269,Mxico

    cDepartamentodeBiologa,FacultaddeQumica,UniversidadNacionalAutnomadeMxico,MxicoD.F.,04510,MxicodNeurobiologaMolecularyCelular,INNN-UNAM,InstitutoNacionaldeNeurologayNeurociruga ManuelVelascoSurez,MxicoD.F.,14269,Mxico

    Received5July2011;receivedinrevisedform13December2011;accepted22December2011

    Abstract

    Neurologicaldiseasescompriseagroupofheterogeneousdisorderscharacterizedbyprogressivebraindysfunctionandcelldeath.Inthenextyears,these

    diseasesareexpectedtoconstituteaworld-widehealthproblem.Becauseexcitotoxicityandoxidativestressareinvolvedinneurodegenerativediseases,it

    becomesrelevantto describepharmacological therapies designed to activate endogenouscytoprotective systems. Activationof transcription factor Nrf2

    stimulatescytoprotectivevitagenesinvolvedinantioxidantdefense.Inthiswork,weinvestigatedtheabilityoftheantioxidantcurcumintoinducetranscription

    factorNrf2inaneurodegenerativemodelinducedbyquinolinicacidinrats.Animalswereadministeredwithcurcumin(400mg/kg, p.o.)for10days,andthen

    intrastriatallyinfusedwithquinolinicacid(240nmol)onday10oftreatment.Curcuminpreventedrotationbehavior(6dayspost-lesion),striatalmorphological

    alterations(7 dayspost-lesion)and neurodegeneration(1 and3 dayspost-lesion)i nducedbyquinolinicacid.Curcuminalso reducedquinolinicacid-inducedoxidativestress(measuredasproteincarbonylcontent)at6h post-lesion.Theprotectiveeffectsofcurcuminwereassociatedtoitsabilitytopreventthe

    quinolinicacid-induceddecreaseofstriatalintra-nuclearNrf2levels(30and120minpost-lesion),andtotalsuperoxidedismutaseandglutathioneperoxidase

    activities(1daypost-lesion).Therefore,resultsofthisstudysupporttheconceptthatneuroprotectioninducedbycurcuminisassociatedwithitsabilityto

    activatetheNrf2 cytoprotectivepathwayandto increasethetotal superoxidedismutaseandgluta thioneperoxidaseactivities.

    2013ElsevierInc.Allrightsreserved.

    Keywords: Nrf2;Curcumin;Quinolinicacid;Oxidativestress

    1.Introduction

    Neurodegenerationistheresultofpathologicalprocessesproduc-

    ingsevereandspecificpatternsofbraincelldamageinaconcertedmanner [1,2].Neurodegenerativeeventsconstituteamajorcausefor

    development of neurological disorders. Humandiseases coursingwithneurodegenerationinvolveexcitotoxicityasatriggeringevent

    fortheinitiationofdeadlycascades [3-5].Excitotoxicityiscurrentlydefinedasatoxicprocesscharacterizedbyasustainedstimulationof

    excitatoryaminoacidreceptors [6-8],mainlyinvolvingN-methyl-D-aspartatereceptors(NMDAr).Differenttoxiceventsderivedfrom

    excitotoxicityhavebeencharacterizedinexperimentalmodels,and

    they include upregulation of detrimental signalingpathways,dis-

    ruptedCa2+ homeostasis,andrecruitmentofreactiveoxygenand

    nitrogenspecies(ROS/RNS),withfurtheroxidative/nitrosativestress

    [2,8-11],ultimatelyleadingtocelldeath.Quinolinic acid (QUIN) is a glutamatergic agonist acting on

    NMDAr, preferentially in discrete populations of these receptorscontaining the NR2A and NR2B subunits. This metabolite is

    synthesized in the kynurenine pathway, and is normallypresentat nanomolar concentrations in human and rat brains [12].

    However, under pathological conditions, kynurenine pathway isstimulatedto increasethe levels of QUIN, thereforeaugmenting

    therisk forexcitotoxic events.Then, thistoxicmetabolite exertsexcessiveexcitationofNMDArandrecruitsenhancedcytoplasmic

    Ca2+ concentrations, mitochondrial dysfunction, decreased ATP

    levels,cytochromecreleaseandoxidativestress,furtherleadingto

    selectiveloss of GABAergic and cholinergic neurons [13]. Indeed,wheninjectedintothebrain,QUINreproducesneurodegenerative

    events in rodents, resembling those observed in the brains of

    patients with Huntington's disease [14]. In addition, the intras-

    triatalinfusionofQUINtorodentsstimulateslipidperoxidationin

    thisregionat shorttimes [15],andthese findingsarerelatedto

    increased extracellular levels of hydroxyl radical (OH) in the

    samebrainregion [16].Furthermore,QUINisknowntogeneratea

    dysregulation in the oxidant/antioxidant ratio by affecting the

    Available online at www.sciencedirect.com

    JournalofNutritionalBiochemistry24(2013)14 24

    ThisworkwassupportedbyCONACYT(GrantNo.103527toPDMand

    129838toJPCH)andbyPAPITIN121910. Correspondingauthor. PatologaVascular Cerebral,InstitutoNacional

    deNeurologayNeurocirugaManuelVelascoSurez,InsurgentesSur3877,

    MxicoD.F.,14269,Mxico.Tel.:+525556063822x2009;fax:+52555424

    0808.

    E-mailaddress: [email protected](P.D.Maldonado).

    0955-2863/$-seefrontmatter2013ElsevierInc.Allrightsreserved.

    http://dx.doi.org/10.1016/j.jnutbio.2011.12.010

    reducedglutathione:oxidizedglutathione(GSH:GSSG)ratio,aswell

    a s depleting the activity of Cu,Zn-SOD at different post-lesion

    times [17], alsorecruitingthe early andtime-dependent formation

    of peroxynitrite (ONOO-) as a key RNS contr ibuting to this

    game,CA,USA).Allotherreagentswerepurchasedfromotherknowncommercial

    sources.DeionizedwaterfromaMilli-QSystemofMillipore(Bedford,MA,USA)was

    usedforthepreparationofallsolutions.

    2.2.Animals

    15I.Carmona-Ramrezetal./JournalofNutritionalBiochemistry24(2013)14 24

    Search People, Research Interests and Universities

    D ow nlo a

    Curcumin_restore

    1.74 MB

    http://www.academia.edu/attachments/32037871/download_file?st=MTM5NzczOTk2OCwxNzcuNDMuNjUuMjQy&ct=MTM5NzczOTk3MQ%3D%3Dhttp://www.academia.edu/attachments/32037871/download_file?st=MTM5NzczOTk2OCwxNzcuNDMuNjUuMjQy&ct=MTM5NzczOTk3MQ%3D%3Dhttp://www.sciencedirect.com/science/journal/09552863http://dx.doi.org/10.1016/j.jnutbio.2011.12.010http://dx.doi.org/10.1016/j.jnutbio.2011.12.010http://dx.doi.org/10.1016/j.jnutbio.2011.12.010mailto:[email protected]://dx.doi.org/10.1016/j.jnutbio.2011.12.010http://dx.doi.org/10.1016/j.jnutbio.2011.12.010mailto:[email protected]://dx.doi.org/10.1016/j.jnutbio.2011.12.010http://dx.doi.org/10.1016/j.jnutbio.2011.12.010http://dx.doi.org/10.1016/j.jnutbio.2011.12.010http://www.sciencedirect.com/science/journal/09552863http://unam.academia.edu/JulioTob%C3%B3nhttp://www.academia.edu/4712295/Curcumin_restores_Nrf2_levels_and_prevents_quinolinic_acid-induced_neurotoxicity_http://www.academia.edu/http://www.academia.edu/
  • 8/9/2019 @@@@@_____Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity _ Julio Tobn - Aca

    2/9

    17/4/2014 Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity| Julio Tobn - Academia.edu

    http://www.academia.edu/4712295/Curcumin_restores_Nrf2_levels_and_prevents_quinol inic_acid- induced_neurotoxici ty_ 2/9

    para gm . otewort y, t ese an o t er a t erat ons n uce

    by QUIN can be prevented by different antioxidants such as

    melatonin, sodium selenite, L-carnitine, epigallocatechin gallate,

    etc. [15,19-21].Thisevidencehighlightsasubstantialcontributionof oxidative stress to the toxic pattern elici ted by QUIN.

    Consequently,itcanbeassumedthatagentsexhibitingantioxidantproperties may have potential therapeutic valueat experimental

    levelinthisandothermodels.Curcumin(CUR),thepolyphenolicnon-flavonoidyellowbioac-

    tivecomponent of turmeric thepoweredrhizome of Curcuma

    longa Linn ,hasbeenshowntoproduceawiderangeofpositive

    biological effects through its antioxidant and anti-inflammatory

    properties [22,23].CURisnon-toxicandhasbeenshowntobeapotent free radicalscavenger [24,25]. Inaddition,CUR, like other

    polyphenols commonly found in plants, fruits and vegetables,

    competes in efficacywith vitamins C and E [26], although recentfindingshaveattributedpartofitsanti-in flammatoryefficacytoits

    morestablemetabolitetetrahydrocurcumin [27].Nevertheless,CUR

    itself has been shown to cross the blood-brain barrier to exert

    neuroprotective effects,suchas those reportedagainst homocyste-

    ine-inducedcognitiveimpairment andoxidative stressin rats [25]. CUR

    alsoinhibits amyloid toxicity in vivo [28] and improves memory

    functionsinastreptozotocin-induceddementiamodelinratsthroughinsulin receptors [29]. One of the most relevant findingson CUR

    researchis thedescriptionofits capacitytoupregulatethemaster

    antioxidantcoordinator,transcriptionfactornuclear factorerythroid2-

    related factor2 (Nrf2), whichin turn is responsible forphase 2

    antioxidant and detoxification genes expression, such as heme

    oxygenase-1,andthiseffectofCURisabletoprotecttheratbrain

    fromfocalischemia [23].

    DespiteafewgroupshavealreadydescribedprotectiveeffectsofCURon QUIN-inducedtoxicity includingantiperoxidativeactionsin rat brain homogenates [30], as well as antiexcitotoxic and

    antioxidant effectsin primaryculturesof humanneurons [21] ,

    to our knowledge there are no reports on the effects of thispolyphenoliccompoundinthetoxicmodelinducedbyQUINunder

    invivoconditions,noronapossibleinvolvementofNrf2inCUR-induced neuroprotection. Therefore, theaim of thiswork wasto

    evaluateifCURcanattenuateorpreventtheQUIN-inducedinvivotoxicity in rats, and whether this effect is dependenton Nrf2

    upregulation.OurresultssupportaroleoftheNrf2pathwayintheneuroprotectiveactionsofCURinthisparadigm.

    2.Methodsandmaterials

    2.1.Reagentsandchemicals

    CUR,QUIN,apomorphine,2,4-dinytrophenilhydrazine(DNPH),guanidinehydro-

    chloride,4-(2-hydroxyethyl)-1-piperazineethanesulfonicacid (HEPES),sodium fluo-

    ride(NaF), phenylmethylsulfonylfluoride,sodium pyrophosphate,sodium vanadate

    (Na3VO4), ethylenediaminetetraacetic acid(EDTA), ethylene glycoltetraacetic acid

    (EGTA),Nonidet P-40,glycerol, sodiumdodecylsulfate (SDS),leupeptin, glutathione

    (GSH),glutathionereductase,NADPH,xanthine,xanthineoxidase,nitrobluetetrazo-

    lium(NBT),andbovineserumalbumin(BSA),wereobtainedfromSigma-Aldrich(St.

    Louis,MO,USA).Fluoro-jadeB(F-JB)wasobtainedfromMillipore(Bedford,MA,USA).

    Anti-Nrf2antibodyusedforimmunofluorescence(C-20,sc-722)andWesternblot(sc-13032),anti-Lamin B1 antibody (sc-20682), and 4,6-diamidino-2-phenylindole

    dihydrochloride (DAPI, sc-3598)were obtained from Santa CruzBiotechnology

    (SantaCruz,CA,USA).Anti- -tubulinantibody(ab-11307)wasfromAbcam(San

    Francisco,CA,USA). AlexaFluor488 goatanti-rabbitIgG secondaryantibodywas

    obtained from Invitrogen (Carlsbad, CA,USA). Goat-antirabbit IgG horseradish

    peroxidase-conjugate(62-6120)and goat-antimouseIgG horseradishperoxidase-

    conjugate(sc-2005)secondaryantibodiesusedforWesternblotwerefromZymed

    (San Francisco, CA, USA) and Santa Cruz Biotechnology(SantaCruz,CA, USA),

    respectively.Vectashield mountingmedium wasobtained fromVector Labs(Burlin-

    MaleWistarratsinitiallyweighing250 300g,wereusedthroughoutthestudy.

    Forallexperimentalpurposes,animalswerehoused fivepercageinacrylicboxesand

    providedwithstandardcommercialratchow(LabRodentDiet5001;PMIFeedsInc.,

    Richmond,IN,USA)andwateradlibitum.Thehousingroomwasmaintainedunder

    constantconditionsofhumidity(50%10%),temperature(25C3C)andlighting

    (12 h dark-lightcycles). All procedures with animals were carried outstrictly

    accordingto theNationalInstitutes ofHealth Guidelinesfor thecareand useof

    laboratoryanimals andthelocalguidelinesontheethicaluseofanimalsfromthe

    Health Ministry of Mexico. During the experiments, all efforts were made to

    minimizeanimal suffering.

    2.3.Experimentaldesign

    All experiments were performedduringthe morning (starting every dayat

    8:00AM).Theanimalswererandomlydividedintofourgroups,asmentionedbelow:

    1)controlgroup(CT),treatedwithvehicleplussaline;2)CURgroup,treatedwithCUR

    plussaline;3)QUINgroup,treatedwithvehicleplusQUIN;and4)CUR+QUINgroup,

    treatedwithCURplusQUIN.AnimalsfromCURandCUR+QUINgroupsreceivedCUR(100,200or400mg/kg/day,p.o.)for10consecutivedays.CTandQUINgroupsreceived

    vehiclefor10days.CURwasdissolvedincarboxymethylcellulose5%(vehicle).Onday

    10,animalswereintrastriatallyinfusedwith1 lofQUINorsaline.QUIN-treatedrats

    receivedasingleinfusionofQUIN(240nmol/L)intherightstriatum,accordingtothe

    followingstereotaxiccoordinates:+0.5mmanteriortobregma,-2.6lateraltobregma,

    and+4.5mmventraltothedura [31]. TheeffectsofincreaseddosesofCUR(100,200

    and400mg/kg)oncirclingbehavior(6dayspost-lesion)andhistologicalalterations

    (7days post-lesion)inducedby QUINwere firstevaluatedto select an optimum

    protective doseof CUR.The mostprominent protective effect wasobservedwith

    400mg/kg,sothisdosewasusedfromthispointonforfurtherassays.Neurodegenera-

    tion(1and3dayspost-lesion),proteincarbonyllevels(6hpost-lesion),Nrf2activation

    (30and120minpost-lesion),andactivitiesoftotalsuperoxidedismutase(SOD)and

    glutathioneperoxidase(GPx)(1daypost-lesion)weredetermined.

    2.4.Circling behavior

    Motoralterations,assessedasrotationbehavior,wereevaluatedinanimalsfrom

    allexperimentalgroups,accordingtopreviousreports [20,32].SixdaysafterQUIN

    infusion,animalswereadministeredwithapomorphine(1mg/kg, s.c.)andseparatedintoindividualacrylicboxcages.Fiveminuteslater,thenumberofipsilateralrotations

    tothelesionedsidewasrecordedfor1h.Eachrotationwasdefinedasacompleteturn

    (360).Dataareexpressedasthetotalnumberofipsilateralturnsin1h.

    2.5.Histologicalexamination

    Braintissueswerecollectedandhistologicallyprocessedaccordingtoprevious

    descriptions [20,32].Sevendaysafterintrastriatallylesioned,animalsfromallgroups

    wereanesthetized i.p.with0.5mLofsodiumpentobarbitalandperfusedtranscardially

    with 0.9%salinesolution containing heparin(200/1 v/v), followedby 4%p-

    formaldehydeat4C.Brainswereremoved,post-fixedin4%p-formaldehydefor7

    days andembedded in paraffin. Fixedtissues were serially sectionedin an 820

    HistoSTAT microtome(AmericanInstrument Exchange, Inc.,Haverhill,MA, USA).

    Striatalsections(5 m-thick)wereobtainedevery100 m,coveringatotaldistanceof

    300 m(100 manteriorand100 mposteriortotheneedletract).Allsectionswere

    stainedwith hematoxylin-eosin(H&E)to visualizecell bodies,usingan imageanalyzer

    IM100(LeicaCambridge,UK).

    2.6.Quantitativeassessmentof lesions

    Cellcountingin histologically preparedsectionswas performedas previously

    described [32].Thegeneralcriteriatoscoredamagedcellsincludedpyknoticnuclei,

    cytoplasmic vacuolation, neuronal atrophy, interstitial edema and necrosis. The

    numberof damagedand preservedneuronswas obtainedfrom 5randomly selected

    fieldsinthreesectionslidesperbrain.Dataareexpressedaspercentageofdamaged

    neuronsper field.

    2.7.Detectionof neurodegenerationusingF-JBstaini ng

    Braintissuewascollectedandprocessedaccordingtopreviousreports [33,34].

    Oneand three days after intrastriatallylesioned,animals from all groups were

    anesthetized i.p. with0.5 mLof sodium pentobarbital andtranscardiallyperfused

    with 0.9%saline solution containingheparin (200/1v/v), followed by 4% p-

    formaldehyde at4C. Brains wereremovedand post-fixedin 2%p-formaldehyde

    and30%sucrosefor7daysat4C.Tissueswerethensubmergedinoptimalcutting

    temperaturecompoundandfrozenoverliquidnitrogen,followedbycryosectionat

    -25Cina cryostatmicromHM520(ThermoScientific,Pittsburg,PA,USA).Sections

    (22 m-thick) were mounted onto glass slides coated with 0.5% gelatin and

    immersedin 1%NaOHand80% ethanol for5 min, followedfor2 minin70%

    ethanol.Slidesweretransferredto0.06%KMnO4 for10minonashakingtableto

    assess consistent backgroundsuppression betweensections,and thenrinsed in

    distilledwaterfor2min.Sectionswerestainedina0.0004%F-JBplus0.0002%DAPI

    solutionfor20min.Slideswererinsedthricewithdistilledwaterfor1mineachstep.

    Excesswaterwasremoved,placingthesectionsonaslidewarmerat50Cuntilfully

    dry(510min),andthenclearedbyfurtherimmersioninxyleneforatleast1min

    beforecoverslippingwithanon-aqueous,nonfluorescentplasticmountingmedia.

    ImmunofluorescencewasvisualizedwithanimageanalyzerIM100(LeicaCambridge,

    UK)usingagreen filterforF-JBandbluefi lterforDAPI.

    2.8.Protein carbonylcontent

    Asan indexofproteinoxidation,proteincarbonylcontentinthestriataltissue(6h

    post-lesion)wasdeterminedaspreviouslydescribed [32].Assessmentofcarbonyl

    formationwasdoneonthebasisofformationofproteinhydrazonebyreactionwith

    DNPH.Striatalhomogenateswereincubatedwith10%streptomycinsulfatetoremove

    nucleicacidsovernightandcentrifugedat21,000gat4Cfor20min.Further,striatal

    homogenates were treated with 10mM DNPH (in2.5M HCl) for1 h atroom

    temperature,and10%trichloraceticacidwasaddedandcentrifugedat2,500gat4Cfor10min.Pelletwaswashedthreetimeswithethanol/ethylacetate(1:1),dissolved

    with 6 M guanidine hydrochloride (inphosphatebuffer 20 mM,pH 7.4), andcentrifugedat5,000gat4Cfor3mintoremoveinsolublematerial.Absorbancewas

    measuredat370nm.ProteincarbonylcontentisexpressedasnmolDNPH/mgprotein,

    usingthe molarabsorptioncoefficient ofDNPH(22,000 M-1 cm-1).Totalprotein

    concentration wasobtainedbyreadingopticaldensityat 280nm inblanktubes

    preparedin parallel(treatedonlywith2.5M HCl),usinga standardcurveofBSA(0.25

    2mg/ml)preparedin6Mguanidinehydrochloride.

    2.9.Detectiono Nr2 b immuno luorescence

    KCl,1mMphenylmethylsulfonyl fluoride,20mMNaF,1mMsodiumpyrophosphate,

    1mMNa3VO4,1%NonidetP-40,and1 g/mLleupeptin).Homogenateswerethen

    centrifuged at 500g for5 min, thesupernatants were recovered as cytosolic

    fractions,and thenuclear pellets were washedin cold bufferB (10mM HEPES

    pH=8.0,0.1mMEDTA,1mMphenylmethylsulfonyl fluoride,20mMNaF,1mM

    sodiumpyrophosphate, 1 mM Na3VO4, 25% glycerol,0.1 M NaCl, and 1 g/mL

    leupeptin).Afterasecondsteptofcentrifugationat500gfor5min,thenucleiwere

    resuspendedin2%SDShypertoniccoldbufferC(10mMHEPESpH=8.0,0.1mM

    EDTA,1mMphenylmethylsulfonyl fluoride,20mMNaF,1mMsodiumpyrophos-

    phate, 1 mMNa3VO4, 25% glycerol, 0.4 M NaCl, and 1 g/mL leupeptin),and

    sonicated.Cytosolicandnuclearfractionswereresolved inSDS-PAGE(10%), using60 g

    (cytoplasmicfraction) or 80 g (nuclear fraction) protein/lane,transferred into

    Immobilon-P membranes (PVDF, Millipore), and immunoblotted with primary

    antibodies:anti-Nrf2,anti--tubulinandanti-LaminB1(1:1,000).Peroxidase-conju-

    gatedsecondaryantibodies(1:10,000)wereusedtodetecttheproteinsofinterestby

    enhancedchemiluminescence,accordingtoapreviousreport [35]. Thecorresponding

    bandswerequantifiedbydensitometry.

    2.11.SOD activity

    TotalSODactivity(MnSODandCuZnSOD)inhomogenateswasdeterminedusing

    xanthine-xanthineoxidasesystemtoreduceNBT.Mixturereactioncontainedinafinalconcentration:0.122mMEDTA,30.6 MNBT,0.122mMxanthine,0.006%BSA,and

    49mMsodiumcarbonate.Fivehundred lofhomogenates(1:20)wereaddedto2.45 mlof themixture describedabove, then 50 l xanthine oxidase, in a final

    concentrationof2.8U/l,wereaddedandincubatedinawaterbathat27Cfor30min.

    Thereactionwasstoppedwith1mlof0.8mMcupricchlorideandtheopticaldensity

    wasreadat560nm.OnehundredpercentofNBTreductionwasobtainedinatubein

    whichthesamplewasreplacedby distilledwater.T heamountof proteinthatinhibited

    NBTreductionto50%ofmaximumwasdefinedasoneunitofSODactivity.Results

    wereexpressedasU/mgprotein.

    16 I.Carmona-Ramrezetal./JournalofNutritionalBiochemistry24(2013)14 24

  • 8/9/2019 @@@@@_____Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity _ Julio Tobn - Aca

    3/9

  • 8/9/2019 @@@@@_____Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity _ Julio Tobn - Aca

    4/9

    17/4/2014 Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity| Julio Tobn - Academia.edu

    http://www.academia.edu/4712295/Curcumin_restores_Nrf2_levels_and_prevents_quinol inic_acid- induced_neurotoxici ty_ 4/9

  • 8/9/2019 @@@@@_____Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity _ Julio Tobn - Aca

    5/9

    17/4/2014 Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity| Julio Tobn - Academia.edu

    http://www.academia.edu/4712295/Curcumin_restores_Nrf2_levels_and_prevents_quinol inic_acid- induced_neurotoxici ty_ 5/9

  • 8/9/2019 @@@@@_____Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity _ Julio Tobn - Aca

    6/9

    17/4/2014 Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity| Julio Tobn - Academia.edu

    http://www.academia.edu/4712295/Curcumin_restores_Nrf2_levels_and_prevents_quinol inic_acid- induced_neurotoxici ty_ 6/9

  • 8/9/2019 @@@@@_____Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity _ Julio Tobn - Aca

    7/9

    17/4/2014 Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity| Julio Tobn - Academia.edu

    http://www.academia.edu/4712295/Curcumin_restores_Nrf2_levels_and_prevents_quinol inic_acid- induced_neurotoxici ty_ 7/9

  • 8/9/2019 @@@@@_____Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity _ Julio Tobn - Aca

    8/9

    17/4/2014 Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity| Julio Tobn - Academia.edu

    http://www.academia.edu/4712295/Curcumin_restores_Nrf2_levels_and_prevents_quinol inic_acid- induced_neurotoxici ty_ 8/9

  • 8/9/2019 @@@@@_____Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity _ Julio Tobn - Aca

    9/9

    17/4/2014 Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity| Julio Tobn - Academia.edu

    http://www academiaedu/4712295/Curcumin restores Nrf2 levels and prevents quinol inic acid induced neurotoxici ty 9/9

    Job Board About Mission Press Blog Stories We're hiring engineers! FAQ Terms Privacy Copyright Send us Feedback

    Academia 2014

    http://www.academia.edu/feedbackhttp://www.academia.edu/copyrighthttp://www.academia.edu/privacyhttp://www.academia.edu/termshttp://www.academia.edu/FAQhttp://www.academia.edu/hiringhttp://www.academia.edu/storieshttp://blog.academia.edu/http://www.academia.edu/presshttp://www.academia.edu/hiring/missionhttp://www.academia.edu/abouthttp://www.academia.edu/Jobs